1. Last 7 days
    1. Supplementary Data: Table 2

      Case J: proband, Male

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    2. Supplementary Data: Table 2

      Case D: proband, female

      DiseaseAssertion: Hypertrophic cardiomyopathy

      CasePresentingHPOs: HP:0001639 (hypertrophic cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

      MultipleGeneVariants:

      (1) DSC2 Variant:

      Variant: NM_004949.4(DSC2):c.2194T>G (p.Leu732Val)

      ClinVar: 36005, https://www.ncbi.nlm.nih.gov/clinvar/variation/36005/

      gnomAD: 0.001181, https://gnomad.broadinstitute.org/variant/18-28650748-A-C

      (2) DSG2 Variant:

      Variant: NM_001943.4(DSG2):c.1174G>A (p.Val392Ile)

      ClinVar: 36009, https://www.ncbi.nlm.nih.gov/clinvar/variation/36009/

      gnomAD: 0.002137, https://gnomad.broadinstitute.org/variant/18-29111109-G-A

      (3) DSP Variant:

      Variant: NM_001008844.2(DSP):c.1778A>G (p.Asn593Ser)

      ClinVar: 44867, https://www.ncbi.nlm.nih.gov/clinvar/variation/44867/

      gnomAD: 0.0005695, https://gnomad.broadinstitute.org/variant/6-7571692-A-G

    3. Supplementary Data: Table 2

      Case 3:

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: WES, Cytoscan HD SNP array (performed on proband, 3 additional carriers, and parents)

      Variant - paternal: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    4. Supplementary Data: Table 2

      Case 2:

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: WES, Cytoscan HD SNP array (performed on proband, 3 additional carriers, and parents)

      Variant - maternal: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    5. Supplementary Data: Table 2

      Case M:

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, partial testing (MYH7, MYBPC3)

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    6. Supplementary Data: Table 2

      Case C: proband, Male

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, partial testing (MYH7, CSRP3, DES, LMNA, MYBPC3, TNNT2, TNNI3)

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    7. Supplementary Data: Table 2

      Case E: proband, male

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

      MultipleGeneVariants:

      (1) PRDM16 Variant:

      Variant: NM_022114.3(PRDM16):c.2666C>T (p.Pro889Leu)

      ClinVar: 487607, https://www.ncbi.nlm.nih.gov/clinvar/variation/487607/

      gnomAD: 0.0001771, https://gnomad.broadinstitute.org/variant/1-3331186-C-T

    8. Supplementary Data: Table 2

      Case G: proband, Male

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, partial testing (MYH7)

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    9. Supplementary Data: Table 2

      Case I: proband, Male

      DiseaseAssertion: Dilated Cardiomyopathy

      CasePresentingHPOs: HP:0001644 (dilated cardiomyopathy)

      CasePreviousTesting: 12-lead electrocardiogram (ECG), echocardiography, exercise test and 24-hour (or 48-hour) Holter monitoring, cardiac MRI, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplemental table 2

      CaseGenotypingMethod: genomic DNA isolated from peripheral blood, initially analyzed via Sanger Sequencing then by next-generation sequencing using targeted gene panels, variant pathogenicity assed using in silico prediction tools, Haplotype analysis was performed using 16 microsatellite markers around MYH7 (DNA from the 14 probands was analysed, and DNA samples of 6 family members carrying the mutation were used to verify the phase and reconstruct the haplotype Supplementary Data: Table 1)

      Variant: NM_000257.2(MYH7):c.5754C>R (p.Asn1918Lys)

      ClinVar: 66082, https://www.ncbi.nlm.nih.gov/clinvar/variation/66082/

      gnomAD: n/a

    1. Case presentation

      Case: Case report, female, 41yo

      CasePresentingHPOs: HP:0001270, HP:0002094, HP:0007340, HP:0010535, HP:0002540, HP:0003323, HP:0002015, HP:0100749, HP:0001662, HP:0005952 (motor delay, dyspnea, lower limb weakness, sleep apnea, inability to walk, progressive muscle weakness, dysphagia, chest pain, bradychardia, decreased pulmonary function)

      HPOsFreeText: non-smoker, onset of neuromuscular disorders in early childhood, written language delay, difficulty completing exercise, dyspnea and lower limb weakness presenting during patient's first pregnancy (33yo), required mechanical ventilation machine, symptoms of skeletal muscle disorder began after delivery of first child, unable to get up without assistance, unable to climb stairs, required use of cane, walker, then eventually a wheelchair, episodes of paralysis in lower limbs, normal tone/bulk of arm muscles but bilateral weakness in shoulders and upper limbs (MRC scale of 3/5), intact fine finger movements, down-going toes, reduced perception of vibration in lower limbs, needle EMG showed tendency of myotonic potentials, muscle biopsy of left quadricep showed features of end-stage process consistent with chronic myopathy (Fig. 2A-D), forced vital capacity = 27%, forced expiratory volume per second = 29%

      CaseNotHPOs: HP:0001513, HP:0040129 (obese, abnormal nerve conduction velocity)

      NotHPOsFreeText: pronator drift, sensory deficit, ocular muscle involvement

      FamilyInfo: mother died at 66yo due to heart attack associated with non-compaction cardiomyopathy, daughter (11yo) has signs of muscle disorders, congenital muscular torticollis, excessive growing pains, and underdeveloped muscles in half of body

      CaseGenotypingMethod: WES, variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.1370T>G (p.Ile457Arg)

      ClinVar: 560881, https://www.ncbi.nlm.nih.gov/clinvar/variation/560881/

      gnomAD: absent

      MultipleGeneVariants:

      (1) SNCB Variant

      Variant: NM_003085.5(SNCB):c.368C>A (p.Pro123His)

      ClinVar: 7026, https://www.ncbi.nlm.nih.gov/clinvar/variation/7026/

      gnomAD: 0.0001929, https://gnomad.broadinstitute.org/variant/5-176048219-G-T

      (2) GDF6 Variant:

      Variant: NM_001001557.4(GDF6):c.746C>A (p.Ala249Glu)

      ClinVar: 8371, https://www.ncbi.nlm.nih.gov/clinvar/variation/8371/

      gnomAD: 0.001948, https://gnomad.broadinstitute.org/variant/8-97157413-G-T

    1. Supplementary Data table 1

      Case:

      DiseaseAssertion: hypertrophic cardiomyopathy

      CaseHPOFreeText: maximal wall thickness (MWT) ≥15 mm

      CasePreviousTesting: Full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (TNNC1, CSRP3, TCAP, ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CAV3, CRYAB, CTNNA3, DES, DSC2, DSG2, DSP, EMD, FHL1, GLA, JPH2, JUP, LAMA4, LAMP2, LDB3, LMNA, MIB1, MYH6, MYOZ2, MYPN, NEXN, PKP2, PLN, PRDM16, PRKAG2, RBM20, SCN5A, TAZ, TMEM43, TNNC1, TTN, TTR, VCL), electrocardiography

      CaseGenotypingMethod: direct sequencing of all coding intron-exon boundaries of 12 genes (prior to 2012), next-generation sequencing (post 2012)

      Variant: NM_000257.3(MYH7):c.5786C>T (p.Thr1929Met)

      ClinVar: 181397, https://www.ncbi.nlm.nih.gov/clinvar/variation/181397/

      gnomAD: n/a

    1. Supplementary Data: S2 Table

      Case 8: Spanish, 81yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, PCR, Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.3056C>A (p.Thr1019Asn)

      ClinVar: 195720, https://www.ncbi.nlm.nih.gov/clinvar/variation/195720/

      gnomAD: 0.00001591, https://gnomad.broadinstitute.org/variant/14-23892799-G-T

    2. Supplementary Data: S2 Table

      Case 4: Spanish, 67yo, Female

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, PCR, Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.1324C>T (p.Arg442Cys)

      ClinVar: 177897, https://www.ncbi.nlm.nih.gov/clinvar/variation/177897/

      gnomAD: 0.00002121, https://gnomad.broadinstitute.org/variant/14-23898247-G-A

    3. Supplementary Data: S2 Table

      Case 12: Spanish, 83yo, Female

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, PCR, Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.3236G>A (p.Arg1079Gln)

      ClinVar: 177826, https://www.ncbi.nlm.nih.gov/clinvar/variation/177826/

      gnomAD: 0.000007073, https://gnomad.broadinstitute.org/variant/14-23891398-C-T

    4. Supplementary Data: S2 Table

      Case 11: Spanish, 27yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, PCR, Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.5359G>C (p.Glu1787Gln)

      ClinVar: 427207, https://www.ncbi.nlm.nih.gov/clinvar/variation/427207/

      gnomAD: n/a

    5. Supplementary Data: S2 Table

      Case 3: Spanish, 17yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, PCR, Sanger Sequencing

      Variant: NM_000257.3(MYH7):c.1207C>G (p.Arg403Gly)

      ClinVar: 505562, https://www.ncbi.nlm.nih.gov/clinvar/variation/505562/

      gnomAD: n/a

    6. Supplementary Data: S2 Table

      Case 126: Spanish, 12yo, Female

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant: NM_000257.3(MYH7):c.5779A>T (p.Ile1927Phe)

      ClinVar: 487639, https://www.ncbi.nlm.nih.gov/clinvar/variation/487639/

      gnomAD: n/a

    7. Supplementary Data: S2 Table

      Case 49: Spanish, 18yo, Male

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePreviousTesting: Full Testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data table S1

      CaseGenotypingMethod: genomic DNA obtained from blood or saliva, Next-gen sequencing panels of 55 or 78 genes

      Variant1: NM_000257.3(MYH7):c.2890G>C (p.Val964Leu)

      ClinVar: 42938, https://www.ncbi.nlm.nih.gov/clinvar/variation/42938/

      gnomAD: 0.0004383, https://gnomad.broadinstitute.org/variant/14-23893148-C-G

      Variant2: NM_000257.3(MYH7):c.3613G>A (p.Glu1205Lys)

      ClinVar: 179656, https://www.ncbi.nlm.nih.gov/clinvar/variation/179656/

      gnomAD: 0.000004004, https://gnomad.broadinstitute.org/variant/14-23889167-C-T

    1. DiseaseAssertion: Hypertrophic Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in two HCM probands

      Variant: NM_000257.4(MYH7):c.2539A>G (p.Lys847Glu)

      ClinVarID: 177757 https://www.ncbi.nlm.nih.gov/clinvar/variation/177757/

      gnomAD: Not in gnomAD

    2. DiseaseAssertion: Hypertrophic Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, and TTR were all tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 760 HCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in one proband

      Variant: NM_000257.4(MYH7):c.1324C>T (p.Arg442Cys)

      ClinVarID: 177897 https://www.ncbi.nlm.nih.gov/clinvar/variation/177897/

      gnomAD: 0.00005012, http://gnomad.broadinstitute.org/variant/14-23898247-G-A

    3. DiseaseAssertion: Cardiomyopathy

      VariantPreviousTesting: ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, ABCC9, CTF1, DES, EMD, LDB3, LMNA, MYH6, RBM20, SGCD, TAZ, TCAP, TTN, VCL, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, TTR, DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43, CASQ2 and RYR2 were all tested in the PanCM panel.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of the 305 PanCM probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      VariantAddInfo: Seen in one PanCM proband

      Variant: NM_000257.4(MYH7):c.3157C>T (p.Arg1053Trp)

      ClinVar: 181382 https://www.ncbi.nlm.nih.gov/clinvar/variation/181382/

      gnomAD: Not in gnomAD

    4. DiseaseAssertion: None

      VariantPreviousTesting: Some combination of ACTC1, ACTN2, CSRP3, LAMP2, MYBPC3, MYH7, NEXN, PLN, TNNC1, TNNI3, TNNT2, TPM1, ABCC9, CTF1, DES, EMD, LDB3, LMNA, MYH6, RBM20, SGCD, TAZ, TCAP, TTN, VCL, CAV3, GLA, MYL2, MYL3, MYOZ2, PRKAG2, TTR, DSC2, DSG2, DSP, JUP, PKP2, RYR2, TMEM43, CASQ2 and RYR2 were tested via NGS.

      VariantGenotypingMethod: Next-generation sequencing panels were used to sequence and read the genetic information of probands for variants within exons and in +/- 10 nucleotides within the flanking introns of the genes provided above. These variants were then interpreted and filtered for pathogenicity.

      Variant: NM_000257.4(MYH7):c.4668C>A (p.Gly1556=)

      ClinVar: 626810 https://www.ncbi.nlm.nih.gov/clinvar/variation/626810/

      gnomAD: 0.0009022, http://gnomad.broadinstitute.org/variant/14-23885498-G-T

    1. Supplementary Data: Online Table 1a

      Case:

      CaseHPOFreeText: heart transplant

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.495G>A (p.Met165Ile)

      ClinVar: 524948, https://www.ncbi.nlm.nih.gov/clinvar/variation/524948/

      gnomAD: n/a

    2. Supplementary Data: Online Table 2b

      Case 4:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant 1: NM_000257.3(MYH7):c.2863G>A (p.Asp955Asn)

      ClinVar: 264608, https://www.ncbi.nlm.nih.gov/clinvar/variation/264608/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23893175-C-T

      Variant 2: NM_000257.3(MYH7):c.1633G>A (p.Asp545Asn)

      ClinVar: 264607, https://www.ncbi.nlm.nih.gov/clinvar/variation/264607/

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/14-23897049-C-T

      variants asserted to be in cis

    3. Supplementary Data: Online Table 2a

      Case:

      CasePresentingHPOs: HP:0010316 (Ebstein anomaly)

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.847T>G (p.Tyr283Asp)

      ClinVar: 66081, https://www.ncbi.nlm.nih.gov/clinvar/variation/66081/

      gnomAD: n/a

    4. Supplementary Data: Online Table 2b

      Case 3:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant 1: NM_000257.3(MYH7):c.2863G>A (p.Asp955Asn)

      ClinVar: 264608, https://www.ncbi.nlm.nih.gov/clinvar/variation/264608/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23893175-C-T

      Variant 2: NM_000257.3(MYH7):c.1633G>A (p.Asp545Asn)

      ClinVar: 264607, https://www.ncbi.nlm.nih.gov/clinvar/variation/264607/

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/14-23897049-C-T

      variants asserted to be in cis

    5. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.4075C>T (p.Arg1359Cys)

      ClinVar: 178082, https://www.ncbi.nlm.nih.gov/clinvar/variation/178082/

      gnomAD: 0.000007954, https://gnomad.broadinstitute.org/variant/14-23887513-G-A

    6. Supplementary Data: Online Table 2a

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.4125T>A (p.Tyr1375Ter)

      ClinVar: 579879, https://www.ncbi.nlm.nih.gov/clinvar/variation/579879/

      gnomAD: n/a

    7. Supplementary Data: Online Table 3

      Case:

      CasePreviousTesting: Full sarcomere testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), Additional testing (ABCC9, ACTN2, ANKRD1, BAG3, CALR3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, EMD, GLA, JPH2, JUP, LAMA4, LAMP2, LMNA, MYH6, MYPN, MYOZ1, MYOZ2, PKP2, PLN, PRKAG2, RBM20, RYR2, SCN5A, SGCD, TAZ, TCAP, TMEM43, TNNC1, TTN, VCL and LDB3)

      CaseGenotypingMethod: DNA isolated from peripheral blood, targeted enrichment, next-gen sequencing with panel of 46 genes

      Variant: NM_000257.3(MYH7):c.5534G>A (p.Arg1845Gln)

      ClinVar: 181286, https://www.ncbi.nlm.nih.gov/clinvar/variation/181286/

      gnomAD: 0.000004023, https://gnomad.broadinstitute.org/variant/14-23884229-C-T

    1. Supplementary Data: Table S3

      Case 135:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: suspected LVNC, >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.4010G>A (p.Arg1337Gln)

      ClinVar: 181238, https://www.ncbi.nlm.nih.gov/clinvar/variation/181238/

      gnomAD: 0.0001207, https://gnomad.broadinstitute.org/variant/14-23887578-C-T

    2. Supplementary Data: Table S3

      Case 90:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.745C>T (p.Arg249Ter)

      ClinVar: 407183, https://www.ncbi.nlm.nih.gov/clinvar/variation/407183/

      gnomAD: 0.000003977, https://gnomad.broadinstitute.org/variant/14-23900678-G-A

      MultipleGeneVariants:

      (1) TPM1 Variant:

      Variant: NM_001018004.1(TPM1):c.775A>G (p.Lys259Glu)

      ClinVar: 43687, https://www.ncbi.nlm.nih.gov/clinvar/variation/43687/

      gnomAD: 0.0008382, https://gnomad.broadinstitute.org/variant/15-63363291-A-G

      (2) PRKAG2 Variant:

      Variant: p.Lys133Ile no ClinVar or CAID

    3. Supplementary Data: Table S3

      Case 12:

      DiseaseAssertion: left ventricular noncompaction

      CasePresentingHPOs: HP:0030682 (left ventricular noncompaction)

      CaseHPOFreeText: >7yo, able to hold breath, non compacted segment = distinct 2-layered appearance of trabeculated and compacted myocardium, NC/C ratio > 2.3:1

      CasePreviousTesting: Cardiac MRI using 17-segment model of LV segmentation, ECG, transthoracic echocardiography, full testing (MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1), additional testing listed in supplementary data tables S1 and S2.

      CaseGenotypingMethod: WES, variant enrichment analysis

      Variant: NM_000257.3(MYH7):c.5786C>T (p.Thr1929Met)

      ClinVar: 181397, https://www.ncbi.nlm.nih.gov/clinvar/variation/181397/

      gnomAD: 0.00005308, https://gnomad.broadinstitute.org/variant/14-23882972-G-A

    1. CaseMYH7-19: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.2539A>G (p.Lys847Glu)

      ClinVar: 177757 https://www.ncbi.nlm.nih.gov/clinvar/variation/177757/

      gnomAD: Not in gnomAD

    2. AJV

      CaseAJV: 17 years diagnosis, Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Father (index case) died awaiting cardiac transplant (carried both variants). Two possibly affected relatives.

      CasePresentingHPOs: HP:0001639, HP:0006536 (Hypertrophic cardiomyopathy, Obstructive lung disease)

      HPOsFreeText: Maximum left ventricular hypertrophy at 17 mm, Sudden cardiac death event at 17 years, Maximal wall thickness at 22mm,

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.1954A>G (p.Arg652Gly)

      ClinVar: 177626 https://www.ncbi.nlm.nih.gov/clinvar/variation/177626/

      gnomAD: Not in gnomAD

      Multiple Gene Variants:

      MYBPC3 Variant

      Variant: NM_000256.3:c.2980C>T (p.Leu994Phe)

      ClinVar: 180992 https://www.ncbi.nlm.nih.gov/clinvar/variation/180992/

      gnomAD: European (Non-Finnish) 1.624e-4, Overall 8.461e-5 https://gnomad.broadinstitute.org/variant/11-47355487-G-A

    3. CaseMYH7-11: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.3325A>G (p.Lys1109Glu)

      ClinVar: 492984 https://www.ncbi.nlm.nih.gov/clinvar/variation/492984/

      gnomAD: Not in gnomAD

    4. CaseMYH7-10: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.3592G>T (p.Asp1198Tyr)

      ClinVar: 520451 https://www.ncbi.nlm.nih.gov/clinvar/variation/520451/

      gnomAD: Not in gnomAD

    5. CaseMYH7-31: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: 1 other proband shares this genotype

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.1954A>G (p.Arg652Gly)

      ClinVar: 177626 https://www.ncbi.nlm.nih.gov/clinvar/variation/177626/

      gnomAD: Not in gnomAD

    6. CaseMYH7-18: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.2578A>G (p.Lys860Glu)

      ClinVar: 192312 https://www.ncbi.nlm.nih.gov/clinvar/variation/192312/

      gnomAD: Not in gnomAD

    7. CaseMYH7-2: Australia

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was isolated from peripheral blood. Most participants underwent testing from the Illumina Cardiomyopathy Sequencing Panel, which includes 46 cardiomyopathy related genes. For others, whole exome sequencing or Sanger squencing was used. After the results were returned, variants were filtered for pathogenicity and rarity.

      Variant: NM_000257.3:c.5287G>A (p.Ala1763Thr)

      ClinVar: 177846 https://www.ncbi.nlm.nih.gov/clinvar/variation/177846/

      gnomAD: European (Non-Finnish) 1.238e-4, Overall 7.423e-5 https://gnomad.broadinstitute.org/variant/14-23884476-C-T

    1. 25

      CaseVIII: Brazil, Caucasian

      DiseaseAssertion: Hypertrophic cardiomyopathy

      FamilyInfo: Family history of HCM, 1 other relative without phenotypes

      CasePresentingHPOs: HP:0001712, HP:0001639, HP:0011103 (Left ventricular hypertrophy, Hypertrophic cardiomyopathy, Abnormality of the left ventricular outflow tract)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Cosegregation confirmed for MYH7

      CasePreviousTesting: Only MYH7, MYBPC3, and TNNT2 were tested.

      CaseGenotypingMethod: DNA was extracted from peripheral blood and the above genes were subject to PCR amplification and directly sequenced. The resulting sequences were compared with the reference and filtered for pathogenicity.

      Variant: NM_000257.3:c.4402G>A (p.Glu1468Lys)

      ClinVar: 235033 https://www.ncbi.nlm.nih.gov/clinvar/variation/235033/

      gnomAD: Not in gnomAD

      Multiple Gene Variants

      MYBPC3 Variant

      Variant: NM_000256.3:c.2686G>A (p.Val896Met)

      ClinVar: 42652 https://www.ncbi.nlm.nih.gov/clinvar/variation/42652/

      gnomAD: European (Finnish) 0.02794, Overall 0.006194 https://gnomad.broadinstitute.org/variant/11-47357479-C-T

    1. Supplementary Data Table S3

      Case: 33

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.5656-4G>A

      ClinVar: 516360, https://www.ncbi.nlm.nih.gov/clinvar/variation/516360/

      gnomAD: 0.00006011, https://gnomad.broadinstitute.org/variant/14-23883106-C-T

      MultipleGeneVariants:

      (1) CRYAB Variant

      Variant: c.331G>A (p.Gly111Ser) unregistered variant

      (2) DES Variant

      Variant: NM_001927.4(DES):c.638C>T (p.Ala213Val)

      ClinVar: 44265, https://www.ncbi.nlm.nih.gov/clinvar/variation/44265/

      gnomAD: 0.009280, https://gnomad.broadinstitute.org/variant/2-220284876-C-T

      (3) FKTN Variant

      Variant: NM_006731.2(FKTN):c.1336A>G (p.Asn446Asp)

      ClinVar: 36138, https://www.ncbi.nlm.nih.gov/clinvar/variation/36138/

      gnomAD: 0.01093, https://gnomad.broadinstitute.org/variant/9-108397495-A-G

      (4) MYBPC3 Variant

      Variant: NM_000256.3(MYBPC3):c.2686G>A (p.Val896Met)

      ClinVar: 42652, https://www.ncbi.nlm.nih.gov/clinvar/variation/42652/

      gnomAD: 0.006194, https://gnomad.broadinstitute.org/variant/11-47357479-C-T

    2. Supplementary Data Table S3

      Case: 52

      DiseaseEntity: HCM

      HPOsFreeText: left ventricular hypertrophy (LVH) ≥15 mm

      InheritancePattern: n/a

      CasePreviousTesting: MYBPC3, TNNT2, TNNI3, MYL2, MYL3, TPM1, ACTC1 (59 genes total tested)

      CaseGenotypingMethod: NGS of 59 genes (Supplemental Table S1), pathogenic and likely pathogenic variants confirmed via Sanger Sequencing

      Variant: NM_000257.4(MYH7):c.2451C>A (p.Asn817Lys)

      ClinVar: 235029, https://www.ncbi.nlm.nih.gov/clinvar/variation/235029/

      gnomAD: absent

      MultipleGeneVariants:

      (1) TTN Variant

      Variant: NM_001267550.2(TTN):c.74597_74599CAA[1] (p.Thr24867del)

      ClinVar: 165840, https://www.ncbi.nlm.nih.gov/clinvar/variation/165840/

      gnomAD: absent

    1. Family M52

      Case 7: 47 year old male

      DiseaseAssertion: novel MYH7 R1832C in the index case

      FamilyInfo:His father died at the age of 47 years due to IDC, whereas a sibling of the index case died suddenly within her first year. It was not possible to obtain DNA from the deceased relatives.

      ParentalTesting:NR

      CasePresentingHPOs:HP:0012828,HP:0012835, HP:0034307, HP:0012666

      CaseHPOFreeText: He had an early onset of symptoms, in his third decade as being the age of 33, with severe dilatation of his left ventricle and depressed LVEF, and required HTX 3 years after the onset of symptoms. A left ventricular end diastolic diameter (in mm and indexed by body surface area (cm/m2)); value of 86mm and 3.2cm/m2. Has a left ventricular ejection fraction of 20%. His clinical status is heart transplantation.

      CaseNotHPOs:NR

      CaseNotHPOFreeText:NR

      CasePreviousTesting:NR

      Genotyping Method:NR

      FunctionalAnalysis:NR

      Variant:NM_000257.4:c.5494C>T

      ClinVar:161322

      CAID:CA016134

      gnomAD: gnomAD v2: 14:23884269 G / A gnomAD v3: 14:23415060 G / A gnomAD v4: chr14-23415060-G-A

      AdditionalInfo: This mutation is located in the rod portion of MYH7 and replaces a basic arginine residue with a reactive neutral cysteine residue in the g-position of the heptad repeat in the α-helical myosin rod, and thus may destabilize the salt bridges required for myosin–myosin dimerization.

    2. Family M57

      Case8: 56 year old male

      DiseaseAssertion: A double heterozygous for the known MYBPC3 R326Q mutation.

      FamilyInfo: His father died due to IDC in his fourth decade, whereas his brother developed IDC. DNA was not available from either of these individuals.

      ParentalTesting:NR

      CasePresentingHPOs:HP:0005110, HP:0034307,HP:0012666, HP:0011675, HP:0005110, HP:0100651

      CaseHPOFreeText: He also developed atrial fibrillation, well regulated on medication. Had onset conditions at age 36. He had left ventricular end diastolic diameter (in mm and indexed by body surface area (cm/m2)); as a value of 65mm and 3.2 cm/m2. A LVEF, left ventricular ejection fraction as 15%. Arrhythmia level as atrial fibrillation. Clinical status as heart transplantation. He also has type 1 diabetes mellitus

      CaseNotHPOs:NR

      CaseNotHPOFreeText:NR

      CasePreviousTesting:NR

      Genotyping Method:NR

      FunctionalAnalysis:NR

      Variant:NM_000256.3:c.977G>A

      ClinVar:42813

      CAID:CA016212

      gnomAD:gnomAD v2: 11:47367871 C / T gnomAD v3: 11:47346320 C / T gnomAD v4: chr11-47346320-C-T

      AdditionalInfo:NR

    3. Family M1

      Case1: A 68-year-old female

      DiseaseAssertion: dilated cardiomyopathy (DCM), with the MYH7 p.Lys637Glu (K637E) variant identified in the affected patient. The study investigated sarcomeric gene variants associated with DCM

      FamilyInfo: The proband's father (M1, II:3) died suddenly at 36 years of age, 2 years after being diagnosed with DCM.

      ParentalTesting: Yes from father

      CasePresentingHPOs: HP:0011664, HP:0011713, HP:0003677, HP:0001635,

      CaseHPOFreeText: was diagnosed as having left ventricular non-compaction (LVNC) based on echocardiography. A left bundle branch block on her ECG. Echocardiography revealed LVNC and she has had a slow progression towards heart failure and an increasing dilatation of her left ventricle. Age 48 at onset, left ventricular end diastolic diameter 59 mm, left ventricular ejection fraction 25%, ventricular extrasystoles for arrhythmia.

      CaseNotHPOs:NR

      CaseNotHPOFreeText:NR

      CasePreviousTesting:NR

      Genotyping Method: genetically screened, also using GenBank with PCR by amplifying the coding region

      FunctionalAnalysis:NR

      Variant: NM_000257.4:c.1909A>G

      ClinVar: 1329402

      CAID:CA389049558

      gnomAD: NR

      AdditionalInfo: NR

    4. Family M20

      Case 3: A 64 year old female

      DiseaseAssertion: The case carried the novel MYH7 K637E mutation

      FamilyInfo: Her mother died of a suspected but unconfirmed cardiac cause; thus, this was regarded as a non-FDC case. Two healthy sisters declined participation in the study.

      ParentalTesting:NR

      CasePresentingHPOs: HP:0003674, HP:0034307, HP:0002372, HP:0011675, HP:0005110

      CaseHPOFreeText: Slowly from onset of symptoms at the age of 42 years, and received HTX in her sixth decade. Has left ventricular end diastolic diameter (in mm and indexed by body surface area (cm/m2)), 81mm and then 4.2m2. LVEF as 15%, ECG as normal. Arrhythmia as atrial fibrillation. NYHA as 4. Clinical status as heart transplantation. CAG has a normal level.

      CaseNotHPOs:NR

      CaseNotHPOFreeText:NR

      CasePreviousTesting:NR

      Genotyping Method: Genetically screened, also using GenBank with PCR by amplifying the coding region

      FunctionalAnalysis: NR

      Variant:NM_000257.4:c.1909A>G

      ClinVar:1329402

      CAID:CA389049558

      gnomAD:NR

      AdditionalInfo:NR

    5. Family M29

      Case6: 48 year old male

      DiseaseAssertion: Carried the MYBPC3 E619K mutation

      FamilyInfo:Three unaffected children were examined (IV:1, IV:2 and IV:3), all with normal echocardiography without signs of hypertrophy or dilatation. Both affected individuals as well as a 26-year-old unaffected daughter (M29, IV:3) carried the MYBPC3 E619K mutation

      ParentalTesting:NR

      CasePresentingHPOs: HP:0034307, HP:0012666, HP:0011713, HP:0001635

      CaseHPOFreeText: Onset of symptoms in their third decade; the index case required heart transplantation 3 years after the onset of symptoms. Has onset at the age of 37. Has left ventricular end diastolic diameter (in mm and indexed by body surface area (cm/m2)) with the value of 79 mm and 3.2 cm/m2. They have a 20% of left ventricular ejection fraction. ECG as left bundle branch block. Clinical status as DCM/ congestive heart failure. CAG as normal.

      CaseNotHPOs:NR

      CaseNotHPOFreeText:NR

      CasePreviousTesting:NR

      Genotyping Method:Genetically screened, also using GenBank with PCR by amplifying the coding region

      FunctionalAnalysis:NR

      Variant: NM_000256.3:c.1855G>A

      ClinVar:161303

      CAID:CA011336

      gnomAD: gnomAD v2: 11:47362731 C / T gnomAD v3: 11:47341180 C / T gnomAD v4: chr11-47341180-C-T

      AdditionalInfo:NR

    1. CasePT-110: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.5326A>G (p.Ser1776Gly)

      ClinVar: 177629 https://www.ncbi.nlm.nih.gov/clinvar/variation/177629/

      gnomAD: East Asian 3.007e-4, Overall 4.595e-5 https://gnomad.broadinstitute.org/variant/14-23884437-T-C


      Multiple Gene Variants:

      MYBPC3 Variant:

      Variant is reported as below, but the nucleotide sequence is incorrect. Unable to register

      Variant: NM_000256.3:c.76A>G (p.Ser236Gly)

    2. CasePT-99: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.4199C>G (p.Ala1400Gly)

      ClinVar: 181248 https://www.ncbi.nlm.nih.gov/clinvar/variation/181248/

      gnomAD: Not in gnomAD

    3. CasePT-42: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo: 2 other siblings share the same genotype


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.5317C>A (p.Gln1773Lys)

      ClinVar: 181277 https://www.ncbi.nlm.nih.gov/clinvar/variation/181277/

      gnomAD: Not in gnomAD

    4. CasePT-33: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo: PT-34 is the proband's sibling in Family 17 with the same genotype


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.1615A>G (p.Met539Val)

      ClinVar: 181409 https://www.ncbi.nlm.nih.gov/clinvar/variation/181409/

      gnomAD: Not in gnomAD

    5. CasePT-30: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.2606G>A (p.Arg869His)

      ClinVar: 177667 https://www.ncbi.nlm.nih.gov/clinvar/variation/177667/

      gnomAD: African 1.230e-4, Overall 2.386e-5 https://gnomad.broadinstitute.org/variant/14-23894051-C-T

    6. CasePT-76: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.2334C>G (p.Asp778Glu)

      ClinVar: 265252 https://www.ncbi.nlm.nih.gov/clinvar/variation/265252/

      gnomAD: Not in gnomAD

    7. CasePT-97: United States

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001650, HP:0001658 (Aortic valve stenosis, Myocardial infarction)

      NotHPOsFreeText: N/A

      CaseAddInfo:


      CaseGenotypingMethod: DNA was collected from the participants using blood samples. 18 genes suspected on contributing to HCM were targeted and sequenced. The variants were then located and filtered for pathogenicity.


      Variant: NM_000257.3:c.4159G>A (p.Glu1387Lys)

      ClinVar: 181244 https://www.ncbi.nlm.nih.gov/clinvar/variation/181244/

      gnomAD: South Asian 3.266e-5, Overall 3.977e-6 https://gnomad.broadinstitute.org/variant/14-23887429-C-T

    1. Supplementary Data, Table 2

      Case: Australian

      DiseaseAssertion: HCM

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm

      CasePreviousTesting: electrocardiography, echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1)

      CaseGenotypingMethod: DNA isolated from peripheral blood or buccal swabs, PCR, Sanger sequencing, segregation analysis, haplotype analysis of MYBPC3 and MYH7

      Variant: NM_000257.3(MYH7):c.1324C>T (p.Arg442Cys)

      ClinVar: 177897, https://www.ncbi.nlm.nih.gov/clinvar/variation/177897/

      gnomAD: 0.00002121, https://gnomad.broadinstitute.org/variant/14-23898247-G-A

    2. Supplementary Data, Table 2

      Case: Australian

      DiseaseAssertion: HCM

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm

      CasePreviousTesting: electrocardiography, echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1)

      CaseGenotypingMethod: DNA isolated from peripheral blood or buccal swabs, PCR, Sanger sequencing, segregation analysis, haplotype analysis of MYBPC3 and MYH7

      Variant: NM_000257.3(MYH7):c.1478T>A (p.Met493Lys)

      ClinVar: 192308, https://www.ncbi.nlm.nih.gov/clinvar/variation/192308/

      gnomAD: n/a

    1. Table V

      Case 902: Italian, Female, 25yo at onset

      DiseaseAssertion: HCM

      CasePresentingHPOs: HP:0001712, HP:0000821, HP:0006682, HP:0004756 (left ventricular hypertrophy, hypothyroidism, premature ventricular contractions, ventricular tachycardia)

      CaseHPOFreeText: maximum left ventricular wall thickness of ≥15 mm, LVWT = 19mm, automatic implantable cardioverter defibrillator, LV ejection fraction = 64%

      CasePreviousTesting: echocardiography, Full testing (MYBPC3, MYH7, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1), additional testing: (GLA, LAMP2, PRKAG2), additional genes added with NGS: (TNNC1, MYH6, MYOM1, MYOZ2, ANKRD1, VCL, CALR3, CAV3)

      CaseGenotypingMethod: Genomic DNA extracted from peripheral leukocytes, Sanger sequencing (73 samples), Next-gen sequencing (19 samples)

      Variant: NM_000256.3(MYBPC3):c.2507T>C (p.Met836Thr) written in paper as p.Ile836Thr

      ClinVar: 454315, https://www.ncbi.nlm.nih.gov/clinvar/variation/454315/

      gnomAD: n/a

    1. HCM516

      Case#: HCM516, male, 23 years,

      DiseaseAssertion: HCM

      FamilyInfo: Yes, father and mother has HCM

      CasePresentingHPOs: syncope, chest tightness (HP:0001279, HP:0031352)

      CaseHPOFreeText: inverted T-waves, ST-segment depression, 28mm MLVWT, 67% LVE F, 0.64 E/A ratio, LVOT-PG 44mm

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: sequencing, physical examination, ECG, 3D modeling, statistical analysis

      MultipleGeneVariants:

      (1) Variant: NM_000257.4(MYH7):c.2631G>A (p.Met877Ile)

      ClinVar: 955476 https://www.ncbi.nlm.nih.gov/clinvar/variation/955476/

      CAID: N/A

      gnomAD: absent

      (2) Variant: NM_000257.4(MYH7):c.3134G>A (p.Arg1045His)

      ClinVar: 651054 https://www.ncbi.nlm.nih.gov/clinvar/variation/651054/

      CAID: N/A

      gnomAD: absent

    1. 6

      Case#: 6, female, 45 yr at onset, 66 yr at diagnosis

      DiseaseAssertion: Myopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0100595, HP:0003202, HP:0003715, HP:0100301 (Camptocormia, skeletal muscle atrophy, myofibrillar myopathy, muscle fiber tubular inclusions)

      CaseHPOFreeText: muscle atrophy specifically paraspinal, no clinical signs of the atrophy

      CaseNotHPOs: HP:0003701, HP:0000508, HP:0000602, HP:0002015 (proximal muscle weakness, ptosis, ophthalmoplegia, dysphagia)

      CaseNotHPOFreeText: No ALS, MG, or Parkinson's disease

      CasePreviousTesting: spinal cord imaging, EMG, deltoid muscle, repetitive nerve stimulation, intravenous Prostigmin therapeutic text, screening for anti-ancetylcholine receptor and anti-muscle specific kinase antibodies, left deltoid muscle biopsy

      CaseGenotypingMethod: N/A

      Variant: NM_000257.4(MYH7):c.5329G>A (p.Ala1777Thr)

      ClinVar: 177697 https://www.ncbi.nlm.nih.gov/clinvar/variation/177697/

      CAID: N/A

      gnomAD: 0.0001316 (European/non-Finnish) https://gnomad.broadinstitute.org/variant/14-23884434-C-T

    1. HCM4.1

      CaseHCM4.1: Mixed ancestry

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0000819 (Diabetes mellitus)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: See Table 1

      CaseGenotypingMethod: DNA was extracted from the probands' blood, followed by sequencing of the coding regions and exon/intron boundaries of 15 genes associated with HCM. From there, they were amplified by PCR ampliication and variants were filtered by pathogenicity. Every unclassified variant was confirmed by Sanger sequencing afterwards.

      Variant: NM_000257.3:c.2282C>A (p.Thr761Asn)

      ClinVar: 546292 https://www.ncbi.nlm.nih.gov/clinvar/variation/546292/

      gnomAD: Not in gnomAD

    1. 2

      Case2: Male, 43 years diagnosis, China, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      CasePresentingHPOs: HP:0001639, HP:0001667, HP:0005110 (Hypertrophic cardiomyopathy, Right ventricular hypertrophy, Atrial fibrillation)

      HPOsFreeText: 0 SCD risk factors, NYHA class is II, Right ventricular wall thickness 14.9 mm

      CaseNotHPOs: HP:0002092, HP:0001642, HP:0030680 (Pulmonary arterial hypertension, Pulmonary stenosis, Congenital heart disease)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A


      CaseGenotypingMethod: Probands' genomic DNA was extracted from blood samples. WES was performed, with the resulting sequence data mapped to a reference genome and variants filtered for pathogenicity and predicted effects. All variants identified were confirmed via Sanger sequencing of the respective genes.


      Variant: NM_000257.3:c.2123G>C (p.Gly708Ala)

      ClinVar: 42882 https://www.ncbi.nlm.nih.gov/clinvar/variation/42882/

      gnomAD: Not in gnomAD


      MultipleGeneVariants:

      MYBPC3 Variant:

      Variant: NM_000256.3:c.1000G>A (p.Glu334Lys)

      ClinVar: 177902 https://www.ncbi.nlm.nih.gov/clinvar/variation/177902/

      gnomAD: East Asian 3.338e-3, Overall 2.368e-4 https://gnomad.broadinstitute.org/variant/11-47367848-C-T


      **TTN Variant

      Unknown Variant

      Variant: TTN-E23808K

      CAID: N/A

      gnomAD: N/A


      ACTN2 Variant

      Unknown Variant

      Variant: ACTN2-P32fs

      CAID: N/A

      gnomAD: N/A


      DSC2 Variant

      Unknown Variant, as 3 possible mutations can be responsible for this protein change

      Variant: DSC2-S574R

      CAID: N/A

      gnomAD: N/A


      LAMA4 Variant

      Unknown Variant

      Variant: LAMA4-L1040P

      CAID: N/A

      gnomAD: N/A


      SYNEC2 Variant

      Unknown Variant, as 3 possible mutations can be responsible for this protein change

      Variant: SYNE2-W5861C

      CAID: N/A

      gnomAD: N/A

    1. ARVC-02

      CaseARVC-02: Male, 35 year diagnosis, Caucasian, Germany

      CasePresentingHPOs: HP:0011663, HP:0001635 (Right ventricular cardiomyopathy, Heart failure)

      HPOsFreeText: RVEDD at 61 mm

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: Proband treated with HTx and ICD, Father died of cardiac issues, Brother has heart disease, Patient is heterozygous for MYH7 variant


      CaseGenotypingMethod: Using a Cardiomyopathy gene panel of 46 genes, the proband's DNA was screened for variants. Afterwards, the variants were classified based on pathogenicity and modeled using predictive software.


      Variant: NM_000257.3:c.3715A>G (p.Ile1239Val)

      ClinVar: 265831 https://www.ncbi.nlm.nih.gov/clinvar/variation/265831/

      gnomAD: Not in gnomAD

    1. CaseMYH7-27: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.505A>G (p.Arg169Gly)

      ClinVar: 177664 https://www.ncbi.nlm.nih.gov/clinvar/variation/177664/

      gnomAD: Not in gnomAD

    2. CaseMYH7-5: N/A

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: N/A

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CaseGenotypingMethod: Testing for all 8 sarcomeric genes, plus GLA, LAMP2, and PRKAG2 was initiated in all probands. After the direct sequencing, the variants were filtered for pathogenicity and classified.

      Variant: NM_000257.3:c.2198G>T (p.Gly733Val)

      ClinVar: 181177 https://www.ncbi.nlm.nih.gov/clinvar/variation/181177/

      gnomAD: Not in gnomAD

    1. IV-8

      Case IV-8: Female, Iranian, 36yo

      DiseaseAssertion: DCM

      FamilyInfo: consanguineous family, pedigree in fig. 1

      CasePresentingHPOs: HP:0005162 (left ventricular dysfunction)

      CaseHPOFreeText: New York Heart Association Class = I, left ventricular ejection fraction = 60%, left ventricular internal end-diastolic diameter = 5.0cm, left ventricular internal end-systolic diameter = 3.1cm, interventricular septum = 0.7cm, posterior wall = 0.7cm, normal sinus rhythm, Normal heart valve function

      CaseNotHPOFreeText: Ischemic heart disease

      CasePreviousTesting: ECG

      CaseGenotypingMethod: co-segregation analysis via Sanger sequencing

      Variant: NM_000257.3(MYH7):c.2863G>A (p.Asp955Asn)

      ClinVar: 264608, https://www.ncbi.nlm.nih.gov/clinvar/variation/264608/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23893175-C-T

    2. III-10

      Case III-10: Female, Iranian, 60yo

      DiseaseAssertion: DCM

      FamilyInfo: consanguineous family, pedigree in fig. 1

      CasePresentingHPOs: HP:0001653, HP:0011713, HP:0005162, HP:0005185, HP:0002375 (mitral regurgitation, left bundle branch block, left ventricular dysfunction, systolic dysfunction, hypokinesia)

      CaseHPOFreeText: New York Heart Association Class = II, left ventricular ejection fraction = 15-20%, left ventricular internal end-diastolic diameter = 5.6cm, left ventricular internal end-systolic diameter = 4.3cm, interventricular septum = 0.7cm, posterior wall = 0.6cm, Normal heart valve function, grade II diastolic dysfunction

      CaseNotHPOFreeText: Ischemic heart disease

      CasePreviousTesting: ECG

      CaseGenotypingMethod: co-segregation analysis via Sanger sequencing

      Variant: NM_000257.3(MYH7):c.2863G>A (p.Asp955Asn)

      ClinVar: 264608, https://www.ncbi.nlm.nih.gov/clinvar/variation/264608/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23893175-C-T

      MultipleGeneVariants:

      (1) TNNT2 Variant:

      Variant: NM_000364.3(TNNT2):c.247A>C (p.Asn83His)

      ClinVar: 427814, https://www.ncbi.nlm.nih.gov/clinvar/variation/427814/

      gnomAD: n/a

    3. IV-6

      Case IV-6: Female, Iranian, 34yo at diagnosis, 37yo at study

      DiseaseAssertion: DCM (initially); paper notes that phenotype is more consisted with hypokinetic non-dilated cardiomyopathy based on guideline from ESC working group on myocardial and pericardial diseases (PMID: 26792875)

      FamilyInfo: consanguineous family, pedigree in fig. 1

      CasePresentingHPOs: HP:0001653, HP:0002375 (mitral regurgitation, hypokinesia)

      CaseHPOFreeText: New York Heart Association Class = II, left ventricular ejection fraction = 35%, left ventricular internal end-diastolic diameter = 5.2cm, left ventricular internal end-systolic diameter = 4.2cm, interventricular septum = 0.9cm, posterior wall = 1.0cm, normal sinus rhythm, grade I diastolic function

      CaseNotHPOFreeText:

      CasePreviousTesting: ECG, Full testing (https://hyp.is/2c24ajtuEemXQ-fRmGkjTA/www.sciencedirect.com/science/article/pii/S1769721217300484)

      CaseGenotypingMethod: https://hyp.is/IKjfsDtxEem3Sh8RHHdYSg/www.sciencedirect.com/science/article/pii/S1769721217300484) WES, targeted exome sequence capture using SureSelectXT Human All Excon v5 kig (Agilent), co-segregation analysis via Sanger sequencing

      Variant: NM_000257.3(MYH7):c.2863G>A (p.Asp955Asn)

      ClinVar: 264608, https://www.ncbi.nlm.nih.gov/clinvar/variation/264608/

      gnomAD: 0.000003976, https://gnomad.broadinstitute.org/variant/14-23893175-C-T

      MultipleGeneVariants:

      (1) TNNT2 Variant:

      Variant: NM_000364.3(TNNT2):c.247A>C (p.Asn83His)

      ClinVar: 427814, https://www.ncbi.nlm.nih.gov/clinvar/variation/427814/

      gnomAD: n/a

    1. CaseCM1832: Male, 0 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: No family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Mother is negative for this variant


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.2609G>T (p.Arg870Leu)

      ClinVar: 235031 https://www.ncbi.nlm.nih.gov/clinvar/variation/235031/

      gnomAD: Not in gnomAD

    2. CaseCM0969: Male, 6 years diagnosis, Japan, Asian

      CasePresentingHPOs: HP:0001639 (Hypertrophic cardiomyopathy)

      HPOsFreeText: N/A

      CaseNotHPOs: HP:0001939 (Abnormality of metabolism/homeostasis)

      NotHPOsFreeText: Neuromuscular disease, Malformation syndromes

      CaseAddInfo: Positive family history of cardiomyopathy or sudden death, Proband found in Supplementary Table 2, Variant is asserted as novel, Both father and sister with HCM tested positive for this variant


      CasePreviousTesting: 8 patients with HCM and one with RCM were analyzed by NGS for the eight sarcomere-encoding genes and MYP.

      CaseGenotypingMethod: Probands were subject to PCR amplification and direct sequencing of 64 cardiomyopathy-associated genes, including the eight sarcomere-encoding genes. The variants were then filtered for rarity and tested for pathogenicity.


      Variant: NM_000257.3:c.2777T>C (p.Leu926Pro)

      ClinVar: 525005 https://www.ncbi.nlm.nih.gov/clinvar/variation/525005/

      gnomAD: Not in gnomAD

    1. Family B II: 3

      Case#: male, 43 yrs,

      DiseaseAssertion: FDCM

      FamilyInfo: Family B; sister also proband; brother died of SCD; daughter and father asymptomatic

      CasePresentingHPOs: HP:0012250 (ST segment depression)

      CaseHPOFreeText: severe cardiac enlargement, increased LVEDD (77.8 mm), decreased LVESD (69.8 mm), decreased LVEF (21% < 50%), heart rate 78 beats/min, widened QRS complex (120 ms > 110 ms)

      CaseNotHPOs:

      CaseNotHPOFreeText:

      CasePreviousTesting: N/A

      CaseGenotypingMethod: Sanger sequencing, Genome Analyzer IIx, ECG,

      Variant: NM_000257.4(MYH7):c.3134G>A (p.Arg1045His)

      ClinVar: 651054 https://www.ncbi.nlm.nih.gov/clinvar/variation/651054/

      CAID: N/A

      gnomAD: absent

    2. Family B II: 1

      Case#: female

      DiseaseAssertion: FDCM

      FamilyInfo: Family B; brother also proband; brother died of SCD, niece and father asymptomatic

      CasePresentingHPOs: N/A

      CaseHPOFreeText: N/A

      CaseNotHPOs: N/A

      CaseNotHPOFreeText: N/A

      CasePreviousTesting: N/A

      CaseGenotypingMethod: Sanger sequencing, Genome Analyzer IIx, ECG,

      Variant: NM_000257.4(MYH7):c.3134G>A (p.Arg1045His)

      ClinVar: 651054 https://www.ncbi.nlm.nih.gov/clinvar/variation/651054/

      CAID: N/A

      gnomAD: absent

    1. HCM014

      CaseHCM014: 43 yrs report, Vietnam, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0100749, HP:0001712, HP:0031295 (Chest pain, Left ventricular hypertrophy)

      HPOsFreeText: Maximal LV thickness 27 mm

      CaseNotHPOs: HP:0005110, HP:0001297, HP:0004756 (Atrial fibrillation, Stroke, Ventricular tachycardia)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: The gene panel included 10 sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1, TNNC1, MYH6), 9 genes encoding Z-disk components and Ca2+ homeostasis factors (LDB3, CSRP3, TCAP, VCL, ACTN2, MYOZ2, NEXN, JPH2, PLN), and 4 genes involved in HCM phenocopies (GLA, LAMP2, PRKAG2, TTR), All probands had left ventricular wall thickness >= 15 mm and no other diseases that can cause secondary hypertrophy

      CaseGenotypingMethod: The coding region, flanking sequences, and untranslated regions of each gene were enriched by LC-PCR, amplified, and sequenced on the Illumina MiSeq or MiniSeq platform. Identified variants were then filtered for pathogenicity and confirmed by Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.5135G>A (p.Arg1712Gln)

      ClinVar: 36642 https://www.ncbi.nlm.nih.gov/clinvar/variation/36642/

      gnomAD: 0.00004657, http://gnomad.broadinstitute.org/variant/14-23884860-C-T

    2. CaseHCM133: 64 yrs report, Vietnam, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: Family history of sudden cardiac death

      CasePresentingHPOs: HP:0100749, HP:0001712, HP:0031295 (Chest pain, Left ventricular hypertrophy, Left atrial enlargement)

      HPOsFreeText: Maximal LV thickness 21 mm

      CaseNotHPOs: HP:0005110, HP:0001297, HP:0004756 (Atrial fibrillation, Stroke, Ventricular tachycardia)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: The gene panel included 10 sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1, TNNC1, MYH6), 9 genes encoding Z-disk components and Ca2+ homeostasis factors (LDB3, CSRP3, TCAP, VCL, ACTN2, MYOZ2, NEXN, JPH2, PLN), and 4 genes involved in HCM phenocopies (GLA, LAMP2, PRKAG2, TTR), All probands had left ventricular wall thickness >= 15 mm and no other diseases that can cause secondary hypertrophy

      CaseGenotypingMethod: The coding region, flanking sequences, and untranslated regions of each gene were enriched by LC-PCR, amplified, and sequenced on the Illumina MiSeq or MiniSeq platform. Identified variants were then filtered for pathogenicity and confirmed by Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.3551A>T (p.Gln1184Leu)

      ClinVar: 181226 https://www.ncbi.nlm.nih.gov/clinvar/variation/181226/

      gnomAD: 0.0006115, http://gnomad.broadinstitute.org/variant/14-23889229-T-A

      Multiple Gene Variants

      (1) MYH6 Variant

      Variant: NM_002471.3(MYH6):c.1252G>A (p.Val418Met)

      ClinVar: 44449 https://www.ncbi.nlm.nih.gov/clinvar/variation/44449/

      gnomAD: 0.001954, http://gnomad.broadinstitute.org/variant/14-23870076-C-T

    3. CaseHCM083: 53 yrs report, Vietnam, Asian

      DiseaseAssertion: Hypertrophic Cardiomyopathy

      FamilyInfo: N/A

      CasePresentingHPOs: HP:0002875, HP:0001712, HP:0001667, HP:0001705 (Exertional dyspnea, Left ventricular hypertrophy, Right ventricular hypertrophy, Right ventricular outlet obstruction)

      HPOsFreeText: Maximal LV thickness 18 mm

      CaseNotHPOs: HP:0005110, HP:0001297, HP:0004756 (Atrial fibrillation, Stroke, Ventricular tachycardia)

      NotHPOsFreeText: N/A

      CaseAddInfo: N/A

      CasePreviousTesting: The gene panel included 10 sarcomeric genes (MYH7, MYBPC3, TNNT2, TNNI3, TPM1, MYL2, MYL3, ACTC1, TNNC1, MYH6), 9 genes encoding Z-disk components and Ca2+ homeostasis factors (LDB3, CSRP3, TCAP, VCL, ACTN2, MYOZ2, NEXN, JPH2, PLN), and 4 genes involved in HCM phenocopies (GLA, LAMP2, PRKAG2, TTR), All probands had left ventricular wall thickness >= 15 mm and no other diseases that can cause secondary hypertrophy

      CaseGenotypingMethod: The coding region, flanking sequences, and untranslated regions of each gene were enriched by LC-PCR, amplified, and sequenced on the Illumina MiSeq or MiniSeq platform. Identified variants were then filtered for pathogenicity and confirmed by Sanger sequencing.

      Variant: NM_000257.4(MYH7):c.4159G>A (p.Glu1387Lys)

      ClinVar: 181244 https://www.ncbi.nlm.nih.gov/clinvar/variation/181244/

      gnomAD: 0.00003266, http://gnomad.broadinstitute.org/variant/14-23887429-C-T

    1. 9

      Case: Case 9, male, 69yo

      CasePresentingHPOs: HP:0031318 (myocardial fiber disarray)

      HPOsFreeText: BMI = 25.2kg/m^2, cause of death: accidental head injury, heart weight = 624g, left ventricular thickness = 1.8cm, distribution of myocyte disarray in ventricular septum, area of disarray = 7.8%, grade of fibrosis = 3

      CaseNotHPOs: HP:0031296 (atrial septal hypertrophy)

      CasePreviousTesting: NGS of 81 cardiovascular disorder-related genes (Supplemental Table S1)

      CaseGenotypingMethod: genomic DNA extracted from whole blood, PCR, NGS of 81 cardiovascular disorder-related genes (Supplemental Table S1)

      Variant: NM_000257.4(MYH7):c.2822G>A (p.Arg941His)

      ClinVar: 636633, https://www.ncbi.nlm.nih.gov/clinvar/variation/636633/

      gnomAD: 0.00001590, https://gnomad.broadinstitute.org/variant/14-23893216-C-T?dataset=gnomad_r2_1

  2. www.researchsquare.com www.researchsquare.com